GREEN CROSS WellBeing Corporation (234690) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.037x

Based on the latest financial reports, GREEN CROSS WellBeing Corporation (234690) has a cash flow conversion efficiency ratio of -0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.97 Billion ≈ $-2.69 Million USD) by net assets (₩107.17 Billion ≈ $72.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 234690 net asset quality index to measure how much of total assets are equity-financed.

GREEN CROSS WellBeing Corporation - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how GREEN CROSS WellBeing Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 234690 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

GREEN CROSS WellBeing Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GREEN CROSS WellBeing Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LI Ming Development Construction Co Ltd TWO:6212	-0.035x
Infant Bacterial Therapeutics AB (publ) ST:IBT-B	-0.420x
TK Chemical Corporation KQ:104480	0.005x
Bank Pembangunan Timur Tbk JK:BJTM	0.111x
Ryvu Therapeutics SA WAR:RVU	-0.553x
MCOT Public Company Limited F:OLU1	0.043x
Phinergy Ltd TA:PNRG	-0.265x
Team Precision Public Company Limited BK:TEAM	-0.034x

Annual Cash Flow Conversion Efficiency for GREEN CROSS WellBeing Corporation (2016–2025)

The table below shows the annual cash flow conversion efficiency of GREEN CROSS WellBeing Corporation from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see GREEN CROSS WellBeing Corporation (234690) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩112.70 Billion ≈ $76.38 Million	₩5.73 Billion ≈ $3.88 Million	0.051x	-61.08%
2024-12-31	₩104.95 Billion ≈ $71.13 Million	₩13.71 Billion ≈ $9.29 Million	0.131x	+1372.80%
2023-12-31	₩100.39 Billion ≈ $68.03 Million	₩-1.03 Billion ≈ $-698.19K	-0.010x	-154.11%
2022-12-31	₩96.16 Billion ≈ $65.17 Million	₩1.82 Billion ≈ $1.24 Million	0.019x	-80.72%
2021-12-31	₩88.30 Billion ≈ $59.84 Million	₩8.68 Billion ≈ $5.89 Million	0.098x	+231.95%
2020-12-31	₩83.08 Billion ≈ $56.30 Million	₩-6.19 Billion ≈ $-4.20 Million	-0.075x	-214.49%
2019-12-31	₩83.17 Billion ≈ $56.36 Million	₩5.41 Billion ≈ $3.67 Million	0.065x	-65.52%
2018-12-31	₩28.84 Billion ≈ $19.55 Million	₩5.45 Billion ≈ $3.69 Million	0.189x	+14.22%
2017-12-31	₩24.84 Billion ≈ $16.83 Million	₩4.11 Billion ≈ $2.78 Million	0.165x	+321.59%
2016-12-31	₩20.94 Billion ≈ $14.19 Million	₩-1.56 Billion ≈ $-1.06 Million	-0.075x	--

About GREEN CROSS WellBeing Corporation

KQ:234690 Korea Biotechnology

Market Cap

$93.80 Million

₩138.41 Billion KRW

Market Cap Rank

#19359 Global

#930 in Korea

Share Price

₩7800.00

Change (1 day)

+7.59%

52-Week Range

₩7250.00 - ₩15100.00

All Time High

₩16468.03